10.01.15
Wellness Center USA, Inc. is shipping its flagship product, Psoria-Light, to key areas in the US; notably, New York, Miami, Cleveland, and Chicago, with more on the way. Psoria-Light is billed as the first FDA-cleared, Deep UV LED Phototherapy device for treating skin diseases such as psoriasis, eczema, vitiligo and more. The technology isn't cheap with units priced north of $50,000. Still, company executives are confident that Psoria-Light will find a market among physicians and clinics.
“I strongly believe that Psoria-Light is the best device on the market today for treating skin ailments in all aspects, including efficacy, affordability, and patient comfort. Knowing all along that we had the ultimate device for the market, I am glad we endured the pressures of shipping units later rather than sooner - for the sake of perfection in performance and reliability," insisted John Yorke, managing partner, PDC, the product's distributor.
In addition to Psoria-Light shipments within the US, sales channels are also being established internationally within Canada, Mexico, Latin America, Asia, Europe, and Africa, which will give Psoria-Light significant global exposure in the skin treatment sector whereby more than 700 million people suffer from auto-immune related skin diseases, according to Wellness Center USA.
“We are very excited to have reached this major milestone,” stated Mr. Andrew Kandalepas, CEO of Wellness Center USA, Inc. “Through our Joint Venture, we were able to successfully commercialize the Psoria-Light into a highly effective and viable alternative to today’s stagnating competition,” he continued.
“I strongly believe that Psoria-Light is the best device on the market today for treating skin ailments in all aspects, including efficacy, affordability, and patient comfort. Knowing all along that we had the ultimate device for the market, I am glad we endured the pressures of shipping units later rather than sooner - for the sake of perfection in performance and reliability," insisted John Yorke, managing partner, PDC, the product's distributor.
In addition to Psoria-Light shipments within the US, sales channels are also being established internationally within Canada, Mexico, Latin America, Asia, Europe, and Africa, which will give Psoria-Light significant global exposure in the skin treatment sector whereby more than 700 million people suffer from auto-immune related skin diseases, according to Wellness Center USA.
“We are very excited to have reached this major milestone,” stated Mr. Andrew Kandalepas, CEO of Wellness Center USA, Inc. “Through our Joint Venture, we were able to successfully commercialize the Psoria-Light into a highly effective and viable alternative to today’s stagnating competition,” he continued.